↓ Skip to main content
What is this page? Embed badge

Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma

Overview of attention for article published in Frontiers in immunology, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
7 X users

Readers on

mendeley
35 Mendeley
Summary X

This page is provided by Altmetric.